Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.
Identifieur interne : 002811 ( PubMed/Curation ); précédent : 002810; suivant : 002812Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.
Auteurs : Robert A. Wilcox [Australie] ; Andrew Churchyard ; Henrik H. Dahl ; Wendy M. Hutchison ; Denise M. Kirby ; Dominic ThyagarajanSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2007.
English descriptors
- KwdEn :
- MESH :
- chemical , genetics : DNA, Mitochondrial.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- chemical , ultrastructure : DNA, Mitochondrial.
- drug therapy : Parkinson Disease.
- genetics : Parkinson Disease.
- pathology : Parkinson Disease.
- Adult, Chromosome Deletion, Humans, Male, Pharmacogenetics.
Abstract
We report a patient with an autosomal dominant chronic progressive external ophthalmoplegia phenotype associated with multiple mtDNA deletions in muscle from a family in which linkage analysis excluded mutations in DNA polymerase gamma (POLG), adenine nucleotide translocase (ANT-1) or C10orf2 (Twinkle). She presented with prominent Parkinsonism characterized by prolonged benefit from levodopa (L-dopa) and the later development of L-dopa induced dyskinesias and motor fluctuations. Thus L-dopa responsiveness, L-dopa induced dyskinesias and motor fluctuations may also occur in atypical Parkinsonism of mitochondrial disease, just as they may in multiple system atrophy.
DOI: 10.1002/mds.21416
PubMed: 17357142
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002811
Links to Exploration step
pubmed:17357142Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.</title>
<author><name sortKey="Wilcox, Robert A" sort="Wilcox, Robert A" uniqKey="Wilcox R" first="Robert A" last="Wilcox">Robert A. Wilcox</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Flinders Medical Centre, SA, Australia. robert_wilcox@health.qld.gov.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Flinders Medical Centre, SA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Churchyard, Andrew" sort="Churchyard, Andrew" uniqKey="Churchyard A" first="Andrew" last="Churchyard">Andrew Churchyard</name>
</author>
<author><name sortKey="Dahl, Henrik H" sort="Dahl, Henrik H" uniqKey="Dahl H" first="Henrik H" last="Dahl">Henrik H. Dahl</name>
</author>
<author><name sortKey="Hutchison, Wendy M" sort="Hutchison, Wendy M" uniqKey="Hutchison W" first="Wendy M" last="Hutchison">Wendy M. Hutchison</name>
</author>
<author><name sortKey="Kirby, Denise M" sort="Kirby, Denise M" uniqKey="Kirby D" first="Denise M" last="Kirby">Denise M. Kirby</name>
</author>
<author><name sortKey="Thyagarajan, Dominic" sort="Thyagarajan, Dominic" uniqKey="Thyagarajan D" first="Dominic" last="Thyagarajan">Dominic Thyagarajan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="doi">10.1002/mds.21416</idno>
<idno type="RBID">pubmed:17357142</idno>
<idno type="pmid">17357142</idno>
<idno type="wicri:Area/PubMed/Corpus">002811</idno>
<idno type="wicri:Area/PubMed/Curation">002811</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.</title>
<author><name sortKey="Wilcox, Robert A" sort="Wilcox, Robert A" uniqKey="Wilcox R" first="Robert A" last="Wilcox">Robert A. Wilcox</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Flinders Medical Centre, SA, Australia. robert_wilcox@health.qld.gov.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Flinders Medical Centre, SA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Churchyard, Andrew" sort="Churchyard, Andrew" uniqKey="Churchyard A" first="Andrew" last="Churchyard">Andrew Churchyard</name>
</author>
<author><name sortKey="Dahl, Henrik H" sort="Dahl, Henrik H" uniqKey="Dahl H" first="Henrik H" last="Dahl">Henrik H. Dahl</name>
</author>
<author><name sortKey="Hutchison, Wendy M" sort="Hutchison, Wendy M" uniqKey="Hutchison W" first="Wendy M" last="Hutchison">Wendy M. Hutchison</name>
</author>
<author><name sortKey="Kirby, Denise M" sort="Kirby, Denise M" uniqKey="Kirby D" first="Denise M" last="Kirby">Denise M. Kirby</name>
</author>
<author><name sortKey="Thyagarajan, Dominic" sort="Thyagarajan, Dominic" uniqKey="Thyagarajan D" first="Dominic" last="Thyagarajan">Dominic Thyagarajan</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Chromosome Deletion</term>
<term>DNA, Mitochondrial (genetics)</term>
<term>DNA, Mitochondrial (ultrastructure)</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (pathology)</term>
<term>Pharmacogenetics</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>DNA, Mitochondrial</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="ultrastructure" xml:lang="en"><term>DNA, Mitochondrial</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Chromosome Deletion</term>
<term>Humans</term>
<term>Male</term>
<term>Pharmacogenetics</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report a patient with an autosomal dominant chronic progressive external ophthalmoplegia phenotype associated with multiple mtDNA deletions in muscle from a family in which linkage analysis excluded mutations in DNA polymerase gamma (POLG), adenine nucleotide translocase (ANT-1) or C10orf2 (Twinkle). She presented with prominent Parkinsonism characterized by prolonged benefit from levodopa (L-dopa) and the later development of L-dopa induced dyskinesias and motor fluctuations. Thus L-dopa responsiveness, L-dopa induced dyskinesias and motor fluctuations may also occur in atypical Parkinsonism of mitochondrial disease, just as they may in multiple system atrophy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">17357142</PMID>
<DateCreated><Year>2007</Year>
<Month>05</Month>
<Day>31</Day>
</DateCreated>
<DateCompleted><Year>2007</Year>
<Month>08</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>22</Volume>
<Issue>7</Issue>
<PubDate><Year>2007</Year>
<Month>May</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.</ArticleTitle>
<Pagination><MedlinePgn>1020-3</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We report a patient with an autosomal dominant chronic progressive external ophthalmoplegia phenotype associated with multiple mtDNA deletions in muscle from a family in which linkage analysis excluded mutations in DNA polymerase gamma (POLG), adenine nucleotide translocase (ANT-1) or C10orf2 (Twinkle). She presented with prominent Parkinsonism characterized by prolonged benefit from levodopa (L-dopa) and the later development of L-dopa induced dyskinesias and motor fluctuations. Thus L-dopa responsiveness, L-dopa induced dyskinesias and motor fluctuations may also occur in atypical Parkinsonism of mitochondrial disease, just as they may in multiple system atrophy.</AbstractText>
<CopyrightInformation>(c) 2007 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilcox</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Flinders Medical Centre, SA, Australia. robert_wilcox@health.qld.gov.au</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Churchyard</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dahl</LastName>
<ForeName>Henrik H</ForeName>
<Initials>HH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hutchison</LastName>
<ForeName>Wendy M</ForeName>
<Initials>WM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kirby</LastName>
<ForeName>Denise M</ForeName>
<Initials>DM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Thyagarajan</LastName>
<ForeName>Dominic</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D002872">Chromosome Deletion</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004272">DNA, Mitochondrial</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010597">Pharmacogenetics</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>8</Month>
<Day>4</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.21416</ArticleId>
<ArticleId IdType="pubmed">17357142</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002811 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002811 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:17357142 |texte= Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:17357142" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |